Home | Welcome to Contract Pharma   
Last Updated Monday, April 21 2014
Print

Topics - Inspections


Refine by Date:
From: To:
By Kristin Brooks
Published March 27, 2014
Areas of toxicity, mutagenicity, analytical and clinical chemistry testing in compliance Read More »
By Kristin Brooks
Published February 11, 2014
Quality Control testing and release Read More »
By Gil Roth
Published February 5, 2014
First-year goals met Read More »
By Kristin Brooks
Published January 27, 2014
Demonstrates proficiency in the safe handling of potent APIs and compounds Read More »
By Kristin Brooks
Published January 24, 2014
Prohibits manufacture and sale of drug ingredients from Toansa plant Read More »
By Kristin Brooks
Published January 21, 2014
Gains approval of Control Testing Lab Read More »
By Gil Roth
Published January 8, 2014
No observations at Manchester, NH site following GMP/PAI visit Read More »
By Kristin Brooks
Published December 17, 2013
IA site GMP compliant, with no Form 483 observations Read More »
By Kristin Brooks
Published December 10, 2013
Expands handling capabilities to all pharmaceutically relevant classes Read More »
By Gil Roth
Published December 10, 2013
Spokane CMO facility cited by agency Read More »
Safebridge Talks Safety
By Gil Roth
Published December 3, 2013
John P. Farris of SafeBridge at AAPS 2013 Read More »
Published December 3, 2013
Expands R&D services after German inspection Read More »
Published December 3, 2013
Prepares for commercial launch of BTG’s Varithena Read More »
By Gil Roth
Published November 18, 2013
Combines microbio validation and screening with rapid detection platform Read More »
By Ed Silverman, Contributing Editor
Published November 13, 2013
Can FDA get tough? Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On